ALLMedicine Schnitzler Syndrome Center
Research & Reviews 103 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.
Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.
Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|
https://doi.org/10.1080/08916934.2019.1680649
Autoimmunity Alix L, Néel A et. al.
Oct 27th, 2019 - Introduction: Schnitzler syndrome is an auto-inflammatory disease defined by chronic urticarial eruption and monoclonal gammopathy. 18F fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is often performed, but its utilit...
https://doi.org/10.1111/jdv.15984
Journal of the European Academy of Dermatology and Venereology : JEADV References; Gusdorf L, Lipsker D
Sep 28th, 2019 - Neutrophilic urticarial dermatosis (NUD) has been described in 2009. Clinically, it is an eruption of rose or red macules or slightly elevated plaques, vanishing within 24 h. It occurs mostly on the trunk and the limbs. Extracutaneous signs such a...
https://clinicaltrials.gov/ct2/show/NCT01245127
Jul 4th, 2019 - Description of the study: Objectives: Primary objective: To evaluate if canakinumab 150mg every 8 weeks can induce and maintain clinical remission in patients with the Schnitzler syndrome. Secondary objectives: To test if canakinumab 150mg can ind...
Clinicaltrials.gov 103 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.
Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.
Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|
https://doi.org/10.1080/08916934.2019.1680649
Autoimmunity Alix L, Néel A et. al.
Oct 27th, 2019 - Introduction: Schnitzler syndrome is an auto-inflammatory disease defined by chronic urticarial eruption and monoclonal gammopathy. 18F fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is often performed, but its utilit...
https://doi.org/10.1111/jdv.15984
Journal of the European Academy of Dermatology and Venereology : JEADV References; Gusdorf L, Lipsker D
Sep 28th, 2019 - Neutrophilic urticarial dermatosis (NUD) has been described in 2009. Clinically, it is an eruption of rose or red macules or slightly elevated plaques, vanishing within 24 h. It occurs mostly on the trunk and the limbs. Extracutaneous signs such a...
https://clinicaltrials.gov/ct2/show/NCT01245127
Jul 4th, 2019 - Description of the study: Objectives: Primary objective: To evaluate if canakinumab 150mg every 8 weeks can induce and maintain clinical remission in patients with the Schnitzler syndrome. Secondary objectives: To test if canakinumab 150mg can ind...
News 1 results
https://www.mdedge.com/dermatology/article/86939/urticaria/successful-treatment-schnitzler-syndrome-canakinumab
Robbie Pesek, MD, Roger Fox, MD
Sep 3rd, 2014 - To the Editor: Schnitzler syndrome occurs with a triad of chronic urticaria, recurring fevers, and monoclonal gammopathy. It was recognized as a clinical entity in 1972; now nearly 200 patients are reported in the medical literature.
